Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 26
- Interviews
Why Curaleaf Laboratories Believes the UK Medical Cannabis Market Is Still Just Getting Started
As the UK’s medical cannabis patient population pushes past an estimated 60,000, questions about market maturity, patient access, and regulatory reform are more pressing than ever.
- Hemp Industry
Texas Edges Closer to Total THC Ban, Raising Alarms Across US Hemp Sector
A battle for the future of the hemp industry in Texas, set to have a significant impact on hemp regulation across the US, is brewing as lawmakers return for a special legislative session marked by sharp divisions between Governor Greg Abbott and Republican leaders in the Senate.
- Press releases
SOMAÍ Announces ‘Official Launch Into Italy’ With Materia Medica Partnership
SOMAÍ, a leading EU-GMP vertically integrated Multi-Country Operator (MCO), continues its rapid expansion into key global markets with its official launch in Italy.
- Uncategorized
Prohibition Partners Unveils Next-Gen Platform for Tracking European Cannabis Trends
As Europe’s medical cannabis markets grow increasingly interconnected, Prohibition Partners has launched a first-of-its-kind digital knowledge hub to offer real-time insight into production, consumption and cross-border flows.
- Industry Trends
Why the UK’s Steady Medical Cannabis Market Growth Is Its Biggest Advantage
Though less explosive than markets like Germany or Australia, the UK has continued to evolve in a more controlled manner, enabling it to largely avoid the scrutiny and intervention that have accompanied rapid expansion elsewhere.
- CBD Market
Could Starmer’s ‘Brexit Reset’ Drag the CBD Industry Back to Square One?
As part of the FSA’s re-energised efforts to push forward with the long-running CBD novel foods approvals process, the agency has continued to actively liaise with industry stakeholders regarding their applications.
- US & Canada
Terrance Cole Confirmed as Permanent DEA Administrator, Seeing Rescheduling Process Placed Firmly in His Hands
Terrance Cole, has been confirmed as the new permanent head of the Drug Enforcement Administration (DEA), and will now be responsible for the future of the landmark cannabis rescheduling project.
- Industry Trends
Has Germany’s Medical Cannabis Market Peaked? New Laws, Surging Supply, and Industry Unrest
Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across Europe and beyond.
- Patient Access
The Polish Pivot: What Happens When Telehealth Meets Regulation
Some see Poland’s telemedicine crackdown as a cautionary tale, others see its subsequent rebound as a beacon of hope. Regardless, it now appears to be the new reality for developing medical cannabis markets.
- US & Canada
GOP Aims to Put Final Nail in the Coffin of Cannabis Rescheduling as Budget Bill Blocks Funding for Reform
The US cannabis rescheduling project, which has been stuck in limbo since being ‘temporarily’ shelved six months ago, is now facing another existential threat from the government’s wide reaching budget.
- US & Canada
Pennsylvania Lawmakers Renew Push for Cannabis Legalisation with Bipartisan Support
Two new bipartisan bills to legalise adult-use cannabis have been introduce by lawmakers in Pennsylvania, reiginiting hopes for advocates and potentially making the state the 25th in the US to push through such legislation.
- International Regulation
Victim of Its Own Success?: German & Australian Regulators Crackdown on Booming Cannabis Telemedicine Sector
Germany’s Ministry of Health has now published a long-feared draft amendment to its Medical Cannabis Act (MedCanG), threatening a crackdown which will be a major cause for concern for hundreds of cannabis businesses, both in and outside of German borders.
